Select a site...
TWN - Biosafety Information Centre
TWN - Finance Information Centre
TWN - Main Site
TWN Indonesia
TWN Chinese
About Us
|
Contact
|
Sitemap
Home
All Publications
Log In
or
Register
Advanced Search
Your cart is empty
$ US Dollar
Currency:
English
echo HEADER_LANGUAGES;?>
Browse TWN Books
International Trade
Finance & Economy
Intellectual Property Rights
Biotechnology/Biosafety
Biodiversity
Climate Change
Environment
Development
Health/Medical
Others
Browse TWN Series
Antimicrobial Resistance
Trade & Development
Global Economy
Intellectual Property Rights
Biodiversity, Knowledge & Rights
Biotechnology & Biosafety
Climate Change
Environment & Development
Gender
Important Links
Third World Resurgence
Third World Economics
South-North Development Monitor (SUNS)
Browse Books by Other Publishers
Other Publishers
Newsletter
Enter your email address to subscribe to our Newsletter.
HTML
TEXT-Only
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Site Map
Discount Coupons
Home
::
Browse TWN Books
::
Intellectual Property Rights
:: WTO/TRIPS Agreement and Access to Medicines: Appropriate Policy Responses
WTO/TRIPS Agreement and Access to Medicines: Appropriate Policy Responses
Product 11/11
USD 15.00
Publisher:
TWN & HAIAP
ISBN:
983-2729-36-X
Year:
2004
No. of pages:
124
Size of book:
16.5cm x 24cm
Author:
Prepared by Robert Weissman
About the Book
A Regional Consultation on "WTO/TRIPS Agreement and Access to Medicines : Appropriate Policy Responses" was held in Colombo from 17-19 April 2003.
It was hosted by the Ministry of Health, Sri Lanka.Health Action International Asia-Pacific (HAAIP) and the Third World Network (TWN) were the co-organizers while the Department of Essential Drugs and Medicines Policy, Drug Action Programme, (EDM/DAP), World Health Organization(WHO), Geneva and the South-East Asian Regional office of WHO, New Delhi, co-sponsored the consultation.
Among the participants were senior health and trade officials and representatives of health-related NGOs and social movements from 18 Asian and Pacific countries, as well as international experts and resource persons.
This is a summary report of the proceedings.
Contents
1.Opening Remarks
Session II:Public Health , Pharmaceuticals and Patents :An Overview of Issues and Concerns
1.The Relationship Between Patents and Prices
2.Overview of WTO Agreements and Implications for National Industrial, Public ealth and Development Policies
3.Access to Medicines and Intellectual Property:The Debate and the Key Players
4.WHO and Health: Pharmaceutical Policies in the Context of Globalization and TRIPS
5.Question and Answers
Session III : TRIPS and Public Health :Appropriate Policy Responses and the Manual on Good Practices in Public-Health Sensitive Patent Laws
1.Policy Needs and Options for Patents and Access to Medicines
2.Model Legal Provisions and Administrative Practices for Patent Laws
3.Questions and Answers
Session IV: The Doha Declarations on the TRIPS Agreement and Public Health: Maximizing the Flexibilities in TRIPS
1.Key Elements and National Policy Implications of the Doha Declaration
2.Questions and Answers
Session V: Balancing Patent Protection and Public Health Considerations: Use of TRIPS-Consistent Measures Post-Doha
1.Patents, TRIPS , Doha and Access to Medicines:UK Models
2.The US Experience wit Compulsory Licensing and Government Use
3.Review of National Patent Legislation in South and South East Asia
4.Comments
5.Preparing for the Post-2005 Scenario:Choices and Challenges in Integrating Public Health Considerations in Patent Legislation
6.Discussion
Session VI:Domestic Pharmaceutical Production and Capacity:Issues, Experiences and Prospects
1.Thailand Experience in Local ARV Production: A Long-Term Solution in Implementing Successful ARV Programmes
2.India's Pharmaceutical Industry: Current Scenario and Future Prospects
3.Indonesia's Pharmaceutical Industry and Local Production Capacity
4.National Drug Policy of Bangladesh and the Multinationals
5.Domestic ARVs Production and Capacity of China
6.Questions and Answers
Session VII:Working Group Discussions/Country Reports
1.Group A
2.Gropu B
3.Group C
4.Discussion
Session VIII:Panel Discussion on TRIPS Agreement, Public Health and Pharmaceuticals in Asia Pacific
Session IX:Main Conclusions of the Consultation
Annexes
A - Conclusions and Recommendations
B - List of Participants
Add to Cart:
This product was added to our catalog on Thursday 16 February, 2012.
Customers who bought this product also purchased...
An Update on Intellectual Property Claims Related to Global Pandemic Influenza Preparedness (No. 15)
Designing Intellectual Property Policies in Developing Countries
The IMPACT Counterfeit Taskforce, Intellectual Property Rights Enforcement and Seizure of Medicines (No. 13)
Compulsory Licensing: Models for State Practices in Developing Countries, Access to Medicine and Compliance with the WTO TRIPS Accord (No. 6)
Patents, Compulsory Licences and Access to Medicines: Some Recent Experiences (No. 10)
|
Home
|
About Us
|
Contact
|
Sitemap
|
Copyright © 2011 Third World Network. All Rights Reserved